Senhwa Biosciences, Inc. (6492.TWO)
TWD 35.1
(-9.88%)
TWD 35.1
(-9.88%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 300.93 Million TWD | -13.9% |
| 2022 | 349.5 Million TWD | 2.67% |
| 2021 | 340.4 Million TWD | -3.43% |
| 2020 | 352.49 Million TWD | -8.6% |
| 2019 | 385.67 Million TWD | 0.25% |
| 2018 | 384.71 Million TWD | 3.04% |
| 2017 | 373.37 Million TWD | 45.39% |
| 2016 | 256.8 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 70.61 Million TWD | 15.31% |
| 2024 Q1 | 63.87 Million TWD | -23.83% |
| 2023 Q3 | 76.27 Million TWD | 15.54% |
| 2023 Q1 | 74.79 Million TWD | -18.57% |
| 2023 Q2 | 66.01 Million TWD | -11.74% |
| 2023 Q4 | 83.84 Million TWD | 9.93% |
| 2023 FY | 300.93 Million TWD | -13.9% |
| 2022 Q2 | 97.66 Million TWD | 26.44% |
| 2022 FY | 349.5 Million TWD | 2.67% |
| 2022 Q4 | 91.85 Million TWD | 11.01% |
| 2022 Q3 | 82.74 Million TWD | -15.27% |
| 2022 Q1 | 77.24 Million TWD | -5.53% |
| 2021 FY | 340.4 Million TWD | -3.43% |
| 2021 Q4 | 81.76 Million TWD | -6.97% |
| 2021 Q3 | 87.88 Million TWD | 0.0% |
| 2020 FY | 352.49 Million TWD | -8.6% |
| 2019 FY | 385.67 Million TWD | 0.25% |
| 2018 FY | 384.71 Million TWD | 3.04% |
| 2017 FY | 373.37 Million TWD | 45.39% |
| 2016 FY | 256.8 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -91370.517% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -135.716% |
| Level Biotechnology Inc. | 151.99 Million TWD | -97.995% |
| Sagittarius Life Science Corp | 135.85 Million TWD | -121.517% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | -296.707% |
| TaiMed Biologics Inc. | 225.23 Million TWD | -33.612% |
| GlycoNex Incorporation | 995 Thousand TWD | -30145.025% |
| VBI | 32.55 Million TWD | -824.399% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | -17.156% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -54.974% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -553.886% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -150.97% |
| Visgeneer Inc. | 67.48 Million TWD | -345.953% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 180.209% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 41.004% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -370.929% |
| Neith Corporation | 66.87 Million TWD | -350.014% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 79.16% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -925.273% |
| Enimmune corporation | 220.1 Million TWD | -36.727% |
| TaiRx, Inc. | 217.13 Million TWD | -38.596% |
| CHO Pharma, Inc. | 268.99 Million TWD | -11.874% |
| EirGenix Inc. | 236.74 Million TWD | -27.117% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -188.39% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 15.85% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 72.563% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | -13.067% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -508.312% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -27687.442% |
| Lukas Biomedical Inc. | 177.45 Million TWD | -69.59% |
| RBC Bioscience Corporation | 58.35 Million TWD | -415.693% |
| BiOptic Inc. | 108.69 Million TWD | -176.872% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -334275.556% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -333.941% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -11408.145% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 53.265% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -222.424% |
| NaviFUS Corp. | 11.82 Million TWD | -2444.5% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -57.783% |
| Sinew Pharma Inc. | 186.25 Million TWD | -61.575% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -306.547% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -36.543% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -625.484% |
| AP Biosciences Inc | 32.25 Million TWD | -833.054% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 83.737% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -5606.068% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 5.164% |
| Intech Biopharm Corporation | -163.99 Million TWD | 283.504% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 73.349% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -625.466% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | -77.486% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -104.689% |
| TCI GENE Inc. | 174.61 Million TWD | -72.342% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -1671777.778% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | -3.43% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -258.494% |
| PharmaEngine, Inc. | 441.78 Million TWD | 31.882% |
| Savior Lifetec Corporation | 223.36 Million TWD | -34.727% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | -16.292% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 85.075% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -116.705% |
| Acepodia, Inc. | 452.56 Million TWD | 33.504% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 44.367% |